Tennessee, United States of America
88 employees
Founded 2007
Verified active February 2, 2026

Key Highlights

  • AvKARE, LLC has established itself as a trusted provider of pharmaceutical products, securing numerous GPO, FSS, and national contracts.
  • The company's recent introduction of infection control products demonstrates its commitment to expanding its service offerings and addressing critical healthcare needs.
  • AvKARE's strategic partnerships with major government entities and healthcare organizations highlight its reliability and industry standing.
  • The company's focus on innovation and operational excellence ensures it can meet the evolving demands of the healthcare sector.
  • AvKARE's extensive network and robust product portfolio make it a key player in the pharmaceutical distribution industry.

About AvKARE, LLC

AvKARE, LLC is a leading generic pharmaceutical manufacturer specializing in unit dose, unit of use, and bulk products. Established in 2007, the company serves a wide range of clients including hospital pharmacies, retail pharmacies, and government entities. AvKARE has secured numerous GPO, FSS, and national contracts, underscoring its reliability and industry standing. The company recently introduced its own line of infection control products, expanding its service offerings.

Headquartered in Pulaski, Tennessee, AvKARE employs 88 professionals dedicated to delivering high-quality pharmaceutical solutions. The company's strategic partnerships with the DOD, VA, VHA, NIH, CDC, HHS, and all US Armed Forces highlight its commitment to serving critical sectors. AvKARE's extensive network and robust product portfolio make it a key player in the pharmaceutical distribution industry.

AvKARE's mission is to provide essential pharmaceutical products efficiently and reliably, ensuring that healthcare providers have access to the medications they need. The company's focus on innovation and operational excellence enables it to meet the evolving demands of the healthcare sector.

Connect with AvKARE, LLC

Why Contact AvKARE, LLC?

B2B professionals should contact AvKARE, LLC for high-quality pharmaceutical products and innovative infection control solutions. The company's extensive network and reliable service make it an ideal partner for healthcare providers and government entities.

Who Should Contact AvKARE, LLC for Business?

Sales teams selling pharmaceutical products, recruiters seeking roles in the pharmaceutical industry, and partners offering healthcare solutions should reach out to AvKARE, LLC.

Categories

  • Pharmaceutical Manufacturing
  • Unit Dose Products
  • Infection Control
  • Healthcare Supply Chain
  • Generic Pharmaceuticals
  • Hospital Pharmacies
  • Retail Pharmacies
  • GPO Contracts
  • FSS Contracts
  • National Contracts

More Pharmaceutical Manufacturing Companies

Frequently Asked Questions

How many employees does AvKARE, LLC have?
AvKARE, LLC has approximately 88 employees.
Where is AvKARE, LLC headquartered?
Pulaski, Tennessee, United States of America
What industry is AvKARE, LLC in?
AvKARE, LLC operates in Pharmaceutical Manufacturing, Healthcare Supply Chain, Infection Control Products.
When was AvKARE, LLC founded?
AvKARE, LLC was founded in 2007.
What is the email format at AvKARE, LLC?
AvKARE, LLC uses the email format flast@avkare.com.
Is AvKARE, LLC still active?
Yes, AvKARE, LLC was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to AvKARE, LLC?
Research AvKARE, LLC's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.

Ready to Sell to AvKARE, LLC?

Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.

Discover Similar Companies
Find Decision Makers
Outreach Monitoring

View pricing · FAQs · Contact us

Last verified: February 2, 2026

Backed by startup programs from